Literature DB >> 21563905

Protection of bone marrow mesenchymal stem cells from acute lung injury induced by paraquat poisoning.

Huang Yang1, Yin Wen, Jia Bin, Yu Hou-You, Wang Yu-Tong.   

Abstract

OBJECTIVE. To examine the protective effect of bone marrow mesenchymal stem cell (BMSC) transplantation against lung injury induced by paraquat (PQ) poisoning. MATERIALS AND METHODS. Fifty-four female SD rats were randomly divided into four groups: a PQ group, a BMSC treatment group, a BMSC control group, and a normal control group. BMSC, isolated and cultured in vitro, were injected into the tail veins of the rats. The mortality rate, the ratio of lung wet/dry weight, plasma levels of IL-1β, tumor necrosis factor-α (TNF-α), malonaldehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-P(X)), and NF-κBp65 expression in the lung tissues were examined during 14 days after injection. Results. Survival in the PQ group ranged from 8 to 12 days, with an average of 9.6 days. All the rats in the BMSC treatment group survived for more than 14 days. In the BMSC treatment group, the ratio of lung wet /dry weight (P  =  0.02  <  0.05), plasma IL-1β and TNF-α levels (P  =  0.00  <  0.01), MDA levels (P  = 0.03  <  0.05), and expression of NF-κBp65 in the lung tissues (P  =  0.00  <  0.01) were significantly lower than those in the PQ group by day 7 post-injection. However, the SOD and GSH-P(X) levels began to increase (P  =  0.00  < 0.01) compared with the PQ group. There was no significant difference between the BMSC control group and the normal control group (P  >  0.01). DISCUSSION AND CONCLUSION. BMSC transplantation may have the potential to protect against PQ-induced lung injury, by reducing lung edema and lipid peroxidation, inhibiting the release of inflammatory mediators. However, the protective effects require time to develop, and early BMSC transplantation may be more evident during the middle and late stages of therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21563905     DOI: 10.3109/15563650.2011.566882

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  7 in total

Review 1.  Adult stem cells for acute lung injury: remaining questions and concerns.

Authors:  Ying-Gang Zhu; Qi Hao; Antoine Monsel; Xiao-Mei Feng; Jae-Woo Lee
Journal:  Respirology       Date:  2013-07       Impact factor: 6.424

Review 2.  Reactive Oxygen Species in Mesenchymal Stem Cell Aging: Implication to Lung Diseases.

Authors:  Se-Ran Yang; Jeong-Ran Park; Kyung-Sun Kang
Journal:  Oxid Med Cell Longev       Date:  2015-07-26       Impact factor: 6.543

3.  Combined signaling of NF-kappaB and IL-17 contributes to Mesenchymal stem cells-mediated protection for Paraquat-induced acute lung injury.

Authors:  Lichun Zhang; Yu Wang; Haitao Shen; Min Zhao
Journal:  BMC Pulm Med       Date:  2020-07-17       Impact factor: 3.317

4.  Human Amnion-Derived MSCs Alleviate Acute Lung Injury and Hinder Pulmonary Fibrosis Caused by Paraquat in Rats.

Authors:  Liming Gong; Xiuxuan Wang; Shaohua Xu; Futuan Liao; Manhong Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-03-19       Impact factor: 6.543

5.  Suppressing NF-κB and NKRF Pathways by Induced Pluripotent Stem Cell Therapy in Mice with Ventilator-Induced Lung Injury.

Authors:  Yung-Yang Liu; Li-Fu Li; Cheng-Ta Yang; Kai-Hsi Lu; Chung-Chi Huang; Kuo-Chin Kao; Shih-Hwa Chiou
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

6.  Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol.

Authors:  Manoj M Lalu; David Moher; John Marshall; Dean Fergusson; Shirley Hj Mei; Malcolm Macleod; Gilly Griffin; Alexis F Turgeon; Michael Rudnicki; Jason Fishman; Marc T Avey; Becky Skidmore; Jeremy M Grimshaw; Duncan J Stewart; Kavita Singh; Lauralyn McIntyre
Journal:  Syst Rev       Date:  2014-05-23

Review 7.  Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.

Authors:  Lauralyn A McIntyre; David Moher; Dean A Fergusson; Katrina J Sullivan; Shirley H J Mei; Manoj Lalu; John Marshall; Malcolm Mcleod; Gilly Griffin; Jeremy Grimshaw; Alexis Turgeon; Marc T Avey; Michael A Rudnicki; Mazen Jazi; Jason Fishman; Duncan J Stewart
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.